After the pre-incubation of PBMCs from SJS/TEN patients with IL-7/IL-15, the enhancement of the drug-specific response, measured by granzyme B and granulysin release, was inconsistent [20]. This evidence concerns the gene GNLY and toxic epidermal necrolysis.